TORNALATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tornalate, and when can generic versions of Tornalate launch?
Tornalate is a drug marketed by Sanofi Aventis Us and is included in two NDAs.
The generic ingredient in TORNALATE is bitolterol mesylate. Additional details are available on the bitolterol mesylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TORNALATE?
- What are the global sales for TORNALATE?
- What is Average Wholesale Price for TORNALATE?
Summary for TORNALATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 27 |
Patent Applications: | 1,259 |
DailyMed Link: | TORNALATE at DailyMed |
![TORNALATE drug patent expirations Drug patent expirations by year for TORNALATE](/p/graph/s/t/TORNALATE-patent-expirations.png)
US Patents and Regulatory Information for TORNALATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | AEROSOL, METERED;INHALATION | 018770-001 | Dec 28, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | SOLUTION;INHALATION | 019548-001 | Feb 19, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TORNALATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | AEROSOL, METERED;INHALATION | 018770-001 | Dec 28, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | SOLUTION;INHALATION | 019548-001 | Feb 19, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | SOLUTION;INHALATION | 019548-001 | Feb 19, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | AEROSOL, METERED;INHALATION | 018770-001 | Dec 28, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TORNALATE
See the table below for patents covering TORNALATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 773437 | ⤷ Sign Up | |
Israel | 34148 | ESTERS OF AMINO METHYL-4-HYDROXY-BENZYL ALCOHOLS,PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | ⤷ Sign Up |
Switzerland | 522589 | Procédé de préparation d'esters d'alcools dihydroxybenzyliques à fonction alcoolique secondaire | ⤷ Sign Up |
Finland | 54796 | ⤷ Sign Up | |
Ireland | 34583 | CARBOXYLIC ESTERS OF HYDROXYPHENYLALKANOLAMINES | ⤷ Sign Up |
Netherlands | 7004671 | ⤷ Sign Up | |
Austria | 300762 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |